Adial Pharmaceuticals Inc... (ADIL)

0.75

-0.04 (-4.46%)

At close: Mar 03, 2025, 3:59 PM

0.73

-2.19%

After-hours: Mar 03, 2025, 05:32 PM EST

Adial Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Net Income	-7M	-12.73M	-19.42M	-10.89M	-8.59M	-11.63M	-1.14M	-420.2K	-817.99K
Depreciation & Amortization	564.00	60.5K	55.11K	564.00	565.00	563.00	565.00	565.00	565.00
Stock-Based Compensation	1.82M	3.37M	4.24M	2.01M	1.6M	5.37M	205.4K	153.56K	250.82K
Other Working Capital	-634.79K	-1.48M	1.82M	786.48K	117.64K	-814.51K	11.55K	-8.32K	100.29K
Other Non-Cash Items	1.07M	-522K	1.81M	1.56M	441.76K	1.13M	102.26K	7.00	1.09K
Deferred Income Tax	-1.91M	-502	-94.08K	-1.56M	n/a	3.48M	n/a	n/a	n/a
Change in Working Capital	-794.21K	-1.37M	1.46M	1.25M	208.17K	-849.32K	336.37K	-8.32K	100.29K
Operating Cash Flow	-6.81M	-11.19M	-11.95M	-7.63M	-6.34M	-2.5M	-494.86K	-274.38K	-465.22K
Capital Expenditures	6.81M	n/a	-64.61K	n/a	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	30.59K	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1.5M	n/a	-0.00	-350K	n/a	n/a	35.12K	n/a	n/a
Investing Cash Flow	1.5M	n/a	-34.02K	-350K	n/a	n/a	35.12K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	-75K	350K	200K	n/a
Common Stock Repurchased	-1.66K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.86K	1.89M	450.01K	1.05M	156.25K	n/a	n/a	n/a
Financial Cash Flow	4.13M	9.13M	13.64M	5.61M	9.25M	6.35M	390K	200K	n/a
Net Cash Flow	-1.17M	-2.06M	1.66M	-2.38M	2.91M	3.85M	-69.75K	-74.38K	-465.22K
Free Cash Flow	n/a	-11.19M	-12.01M	-7.63M	-6.34M	-2.5M	-494.86K	-274.38K	-465.22K